Demographic Characteristics, Survival and Prognostic Factors of Early Breast Cancer Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cohort Study

por Behrouzi, Bita, Mohagheghi, Mohammad Ali, Sadighi, Sanambar
Publicado 2017

Comparison of Three Fixation Methods for Femoral Neck Fracture in Young Adults: Experimental and Numerical Investigations

por Samsami, Shabnam, Saberi, Sadegh, Sadighi, Sanambar, Rouhi, Gholamreza
Publicado 2015

Estimating the treatment effect in patients with gastric cancer in the presence of noncompliance

por Safari, Malihe, Mahjub, Hossein, Esmaeili, Habib, Sadighi, Sanambar
Publicado 2021

Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

por Sadighi, Sanambar, Mohagheghi, Mohammad Ali, Montazeri, Ali, Sadighi, Zahra
Publicado 2006

The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes

por Behrouzi, Bita, Zokaasadi, Mohammad, Mohagheghi, Mohhamad Ali, Emami, Amir Hosein, Sadighi, Sanambar
Publicado 2021

The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome

por Sadighi, Sanambar, Zokaasadi, Mohammad, Kasaeian, Amir, Maghsudi, Somaye, Jahanzad, Issa, Kamranzadeh Fumani, Hosein
Publicado 2017

Down-regulation of immune checkpoints by doxorubicin and carboplatin-containing neoadjuvant regimens in a murine breast cancer model

por Sadighi, Sanambar, Sharifian, Ramezanali, Kazemimanesh, Monireh, Muhammadnejad, Ahad, Shahosseini, Zahra, Amanpour, Saeid, Muhammadnejad, Samad
Publicado 2021

Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study

por Kamranzadeh, Hosein, Ardekani, Reza Manouchehri, Kasaeian, Amir, Sadighi, Sanambar, Maghsudi, Somaye, Jahanzad, Issa, Maleki, Nasrollah
Publicado 2019

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency cl...

por Allahyari, Abolghasem, Ehsanpour, Ali, Ansarinejad, Nafiseh, Mehrzad, Valiollah, Kalantari, Behjat, Raafat, Jahangir, Ghadiany, Mojtaba, Shahi, Farhad, Gharib, Behrooz, Moazed, Vahid, Khosravi, Adnan, Mirpour, Mir Hossein, Salari, Sina, Mortazavizadeh, Seyedmohammadreza, Nekoyi, Amirabbas, Khani, Mohsen, Sadeghi, Alireza, Gharib, Sirus, Bary, Alireza, Mirzania, Mehrzad, Haghighat, Shirin, Razavi, Seyed Mohsen, Emami, Seyed Amir Hossein, Hosseinzadeh, Mehran, Mirbolouk, Mahdi, Sadighi, Sanambar, Shahrasbi, Abdolali, Esfahani, Ali, Gity, Masoumeh, Anjidani, Nassim, Kafi, Hamidreza, Najafi, Safa
Publicado 2022

Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, eq...

por Allahyari, Abolghasem, Ehsanpour, Ali, Najafi, Behrouz, Ansarinejad, Nafseh, Mehrzad, Valiollah, Kalantari, Behjat, Raafat, Jahangir, Ghadiany, Mojtaba, Shahi, Farhad, Gharib, Behrooz, Moazed, Vahid, Khosravi, Adnan, Mirpour, Mir Hossein, Salari, Sina, Mortazavizadeh, Seyedmohammadreza, Nekoyi, Amirabbas, Khani, Mohsen, Sadeghi, Alireza, Gharib, Sirus, Bary, Alireza, Mirzania, Mehrzad, Haghighat, Shirin, Razavi, Seyed Mohsen, Emami, Seyed Amir Hossein, Hosseinzadeh, Mehran, Mirbolouk, Mahdi, Sadighi, Sanambar, Shahrasbi, Abdolali, Esfahani, Ali, Gity, Masoumeh, Anjidani, Nassim, Kaf, Hamidreza, Najaf, Safa
Publicado 2022